COST-EFFECTIVENESS ANALYSIS OF OCTREOTIDE LAR VERSUS LANREOTIDE SR FOR THE POSTOPERATIVE TREATMENT OF PATIENTS WITH ACTIVE ACROMEGALY IN CHINA
Author(s)
Xuan J1, Zhang Z2, Wang Y2, Mao Z3, Lu YJ4, Wang R5
1Sun Yat-Sen University, Guangzhou, China, 2Huashan Hospital of Fudan University, Shanghai, China, 3The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China, 4Shanghai Centennial Scientific Co.,Ltd, Shanghai, China, 5Peking Union Medical College Hospital, Beijing, China
Conference/Value in Health Info
2016-05, ISPOR 2016, Washington DC, USA
Value in Health, Vol. 19, No. 3 (May 2016)
Code
PSY42
Topic
Economic Evaluation
Topic Subcategory
Cost-comparison, Effectiveness, Utility, Benefit Analysis
Disease
Rare and Orphan Diseases